Psychopharmacology and Psychiatry Updates Psychopharmacology Institute
-
- 健康與體能
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
-
Highlights From APA 2024: Key Insights on Psychopharmacology
In this episode, the editorial team of the Psychopharmacology Institute discusses 3 important topics presented at the APA Annual Meeting: Prescribing psychiatric medications during pregnancy, recent advances in clozapine treatment, and managing eating disorders, namely anorexia nervosa and bulimia nervosa. The episode covers the safety and dose adjustments for medications like SSRIs, lamotrigine, and lithium during pregnancy; early initiation and monitoring of clozapine; and effective treatments, including psychotherapy, olanzapine, and fluoxetine for eating disorders.
Hosts: Flavio Guzman, M.D., Paz Badia, M.D., and Lorena Rodriguez, M.D.
-
Antidepressants in Pregnancy: Weighing the Evidence
In this episode, we discuss a new study on maternal depression, antidepressant use, and pregnancy complications. Can antidepressants during pregnancy harm the baby? Dr. Lauren Osborne helps us weigh the risks and benefits.
Faculty: Lauren Osborne, M.D.
Host: Richard Seeber, M.D.
Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 56 Neonatal and Pregnancy Complications Following Maternal Depression or Antidepressant Exposure -
Unraveling the Pharmacological Puzzle of Fibromyalgia
In this episode, we explore the most effective pharmacologic treatments for fibromyalgia, a complex nociplastic pain syndrome. Dr. Daniel Clauw shares his insights on the top drug classes for managing fibromyalgia and discusses why opioids should be avoided. Could the hyperactive endogenous opioid system in fibromyalgia patients explain the ineffectiveness of opioids?
Faculty: Daniel Claw, M.D.
Host: Richard Seeber, M.D.
Learn more about our memberships here Earn 0.75 CME: Nociplastic Pain Syndromes: Focus on Fibromyalgia Pharmacologic Therapies for Fibromyalgia -
Weighing the Evidence: Antipsychotics in Pediatric Anorexia Nervosa
In this episode, we explore the use of antipsychotic medication in treating children and adolescents with anorexia nervosa. Can these medications play a role in promoting weight gain and reducing comorbid symptoms? Or do the risks outweigh the potential benefits in this vulnerable population?
Faculty: David Rosenberg, M.D.
Host: Richard Seeber, M.D.
Learn more about our membership here Earn 0.5 CME: CAP Smart Takes Vol. 15 Antipsychotics in the Treatment of Youth With Anorexia Nervosa -
Beyond the Pain: Diagnosing Fibromyalgia
In this episode, we dive into the diagnosis of fibromyalgia, a common nociplastic pain syndrome. We explore how to assess widespread pain and associated symptoms and how to understand fibromyalgia as a spectrum rather than a binary diagnosis. How can this nuanced approach help us tailor treatment strategies?
Faculty: Daniel Clauw, M.D.
Host: Richard Seeber, M.D.
Learn more about our memberships here Earn 0.75 CME: Nociplastic Pain Syndromes: Focus on Fibromyalgia Diagnosing Fibromyalgia -
Informed Consent and SSRIs: Discussing the Risk of Irreversible Sexual Side Effects
In this episode, we delve into the potential for irreversible sexual dysfunction after SSRI use, based on a large-scale Israeli study. Could a few months or even days of antidepressant treatment lead to permanent erectile issues?
Faculty: Paul Zarkowski, M.D.
Host: Richard Seeber, M.D.
Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 55 Risk of Irreversible Post‑SSRI Sexual Dysfunction With Antidepressants